Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a virtual ward get you home from the hospital faster?

NCT ID NCT06936891

Knowledge-focused Sponsor: Erasmus Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checks if it's possible to send some hospital patients home early and monitor them remotely using a smartphone app and vital sign tracking. Researchers want to see if at least 30% of eligible patients can safely use this virtual ward. The goal is to reduce hospital stays while keeping care quality high.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 306 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years old). * Currently hospitalized and eligible for early discharge according to clinical judgment. * Ability to provide written informed consent. * Access to a smartphone or tablet with internet connection. * Patient is capable of using the Digizorg app or has support from a caregiver who can assist. * Suitable home situation for Virtual Ward care (e.g., safe environment, necessary utilities available). * Enrollment in one of the predefined Virtual Ward care pathways Exclusion Criteria: * Patients requiring continuous hospital-based monitoring or interventions that cannot be safely delivered at home. * Patients who are hemodynamically unstable or require oxygen therapy \>5 liters/minute at the time of discharge. * Patients unable or unwilling to comply with home monitoring procedures. * Patients with significant cognitive impairment without adequate caregiver support. * Patients with a life expectancy less than 30 days, as assessed by the treating physician. * Patients participating in another interventional clinical trial that could interfere with the Virtual Ward protocol. * Any other condition that, in the opinion of the treating physician, would make participation unsafe or infeasible.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Early discharge are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Early discharge Feasibility studies Hospital at home Telemedicine Virtual clinic

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Erasmus Medical Center

    RECRUITING

    Rotterdam, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.